Kiora Pharmaceuticals Inc. (KPRX)
NASDAQ · Healthcare
Kiora Pharmaceuticals Inc. Shareholder Equity 2015–2025
Kiora Pharmaceuticals Inc. annual/quarterly shareholder equity history from 2015 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Kiora Pharmaceuticals Inc. shareholder equity for the quarter ending December 31, 2025 were 16.1M, a 37.40% decrease year-over-year.
- Kiora Pharmaceuticals Inc. shareholder equity for 2025 were 16.1M, a 37.40% decrease from 2024.
- Kiora Pharmaceuticals Inc. shareholder equity for 2024 were 25.8M, a 321.62% increase from 2023.
- Kiora Pharmaceuticals Inc. shareholder equity for 2023 were 6.1M, a 58.09% decrease from 2021.
- Kiora Pharmaceuticals Inc. shareholder equity for 2021 were 14.6M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Kiora Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $16 |
| 2024 | $26 |
| 2023 | $6 |
| 2021 | $15 |
| 2020 | $10 |
| 2019 | $7 |
| 2018 | $9 |
| 2017 | $-2 |
| 2016 | $-0 |
| 2015 | $6 |
| Kiora Pharmaceuticals Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $16 |
| 2024-12-31 | $26 |
| 2023-12-31 | $6 |
| 2021-12-31 | $15 |
| 2020-12-31 | $10 |
| 2019-12-31 | $7 |
| 2018-12-31 | $9 |
| 2017-12-31 | $-2 |
| 2016-12-31 | $-0 |
| 2015-12-31 | $6 |
Kiora Pharmaceuticals Inc. Shareholder Equity — FAQ
Kiora Pharmaceuticals Inc. (KPRX) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KPRX's shareholder equity history?
The chart and table above show Kiora Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.